Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein

Virology

Volumn 252, Issue 2, 1998, Pages 304-312

  Lukac, David M ^a   Renne, Rolf ^a   Kirshner, Jessica R ^a   Ganem, Don ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN HERPESVIRUS 8; INFECTION RISK; KAPOSI SARCOMA; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REPORTER GENE; TRANSACTIVATION; VIRUS EXPRESSION; VIRUS GENE; VIRUS GENOME; VIRUS LATENCY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 8;

EID: 0032567394     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9486     Document Type: Article

References (42)

1. Ambroziak J., Blackbourn D., Herndier B., Glogan R., Gullet J., McDonald A., Lennette E., Levy J. Herpesvirus-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients (technical comment). Science. 268:1995;582-583.
2. Beral V. Epidemiology of Kaposi's Sarcoma. Cancer Surveys. 10:1991;5-22.
3. Bigoni B., Dolcetti R., de Lellis L., Carbone A., Boiocchi M., Cassai E., Di Luca D. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J. Infect. Dis. 173:1996;542-549.
4. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N. H., Tschachler E., Colombini S., Ensoli B., Sturzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:1997;7963-7968.
5. Brazas R., Ganem D. A cellular homolog of hepatitis delta antigen: Implications for viral replication and evolution. Science. 274:1996;90-94.
6. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas [see comments]. N. Engl. J. Med. 332:1995;1186-1191.
7. Chan S. R., Bloomer C., Chandran B. Identification and characterization of human herpesvirus-8 lytic cycle-associated ORF 59 protein and the encoding cDNA by monoclonal antibody. Virology. 240:1998;118-126.
8. Chandran B., Koelle D. M., Corey L., Horvat R., Goldstein E. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs. Virology. 243:1998;208-217.
9. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
10. Chang Y., Moore P. S. Kaposi's Sarcoma (KS)-associated herpesvirus and its role in KS. Infect. Agents Dis. 5:1996;215-222.
11. Chen C., Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:1987;2745-2752.
12. Countryman J., Miller G. Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA. 82:1985;4085-4089.
13. Gao S. J., Kingsley L., Li M., Zheng W., Parravicini C., Ziegler J., Newton R., Rinaldo C. R., Saah A., Phair J., Detels R., Chang Y., Moore P. S. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat. Med. 2:1996;925-928.
14. Gruffat H., Sergeant A. Characterization of the DNA-binding site repertoire for the Epstein-Barr virus transcription factor R. Nucleic Acids Res. 22:1994;1172-1178.
15. Hardwick J. M., Tse L., Applegren N., Nicholas J., Veliuona M. A. The Epstein-Barr virus R transactivation (Rta) contains a complex, potent activation domain with properties different from those of VP-16. J. Virol. 66:1992;5500-5508.
16. Kedes D., Operskalski E., Busch M., Kohn R., Flood J., Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission. Nature Med. 2:1996;918-924.
17. Kieff E. Epstein-Barr virus and its replication. 3rd ed. Fields Virology. 1996;Lippincott-Raven, Philadelphia. p. 2343-2396.
18. Komanduri K. V., Luce J. A., McGrath M. S., Herndier B. G., Ng V. L. The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:1996;215-226.
19. Lagunoff M., Ganem D. The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 236:1997;147-154.
20. Lagunoff, M. Majeti, R. Weiss, A. Ganem, D. 1998, B cell signal transduction by the Kaposi's sarcoma-associated herpesvirus K1 gene product occurs through a non-consensus ITAM in the absence of exogenous ligand.
21. Lee H., Guo J., Li M., Choi J. K., DeMaria M., Rosenzweig M., Jung J. U. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol. Cell. Biol. 18:1998;5219-5229.
22. Lin K., Dai C. Y., Ricciardi R. P. Cloning and functional analysis of Kaposi's sarcoma-associated herpesvirus DNA polymerase and its processivity factor. J. Virol. 72:1998;6228-6232.
23. Liu C., Sista N. D., Pagano J. S. Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F. J. Virol. 70:1996;2545-2555.
24. Martin J. N., Ganem D. E., Osmond D. H., Page-Shafer K. A., Macrae D., Kedes D. H. Sexual transmission and the natural history of human herpesvirus 8 infection. N. Engl. J. Med. 338:1998;948-954.
25. Mesri E. A., Cesarman E., Arvanitakis L., Rafii S., Moore M. A., Posnett D. N., Knowles D. M., Asch A. S. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. J. Exp. Med. 183:1996;2385-2390.
26. Miller G. The switch between latency and replication of Epstein-Barr virus. J. Infect. Dis. 161:1990;833-844.
27. Moore P. S., Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection [see comments]. N. Engl. J. Med. 332:1995;1181-1185.
28. Moore P. S., Gao S. J., Dominguez G., Cesarman E., Lungu O., Knowles D. M., Garber R., Pellett P. E., McGeoch D. J., Chang Y. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J. Virol. 70:1996;549-558.
29. Moore P. S., Kingsley L. A., Holmberg S. D., Spira T., Gupta P., Hoover D. R., Parry J. P., Conley L. J., Jaffe H. W., Chang Y. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS. 10:1996;175-180.
30. Raab M. S., Albrecht J. C., Birkmann A., Yaguboglu S., Lang D., Fleckenstein B., Neipel F. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J. Virol. 72:1998;6725-6731.
31. Renne R., Lagunoff M., Zhong W., Ganem D. The size and conformation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in infected cells and virions. J. Virol. 70:1996;8151-8154.
32. Renne R., Zhong W., Herndier B., McGrath M., Abbey N., Kedes D., Ganem D. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat. Med. 2:1996;342-346.
33. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S., Chang Y., Moore P. S. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA. 93:1996;14862-14867.
34. Schulz T. F. Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J. Gen. Virol. 79:1998;1574-1591.
35. Simpson G. R., Schulz T. F., Whitby D., Cook P. M., Boshoff C., Rainbow L., Howard M. R., Gao S. J., Bohenzky R. A., Simmonds P., Lee C., de Ruiter A., Hatzakis A., Tedder R. S., Weller I. V., Weiss R. A., Moore P. S. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen [see comments]. Lancet. 348:1996;1133-1138.
36. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M., Degos L. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease [see comments]. Blood. 86:1995;1276-1280.
37. Staskus K. A., Zhong W., Gebhard K., Herndier B., Wang H., Renne R., Beneke J., Pudney J., Anderson D. J., Ganem D., Haase A. T. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J. Virol. 71:1997;715-719.
38. Sun R., Lin S., Gradoville L., Miller G. Polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 93:1996;11883-11888.
39. Sun R., Lin S. F., Gradoville Y., Yuan Y., Zhu F., Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA. 95:1998;10866-10871.
40. Whitby D., Howard M. R., Tenant-Flowers M., Brink N. S., Copas A., Boshoff C., Hatzioannou T., Suggett F. E., Aldam D. M., Denton A. S. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma [see comments]. Lancet. 346:1995;799-802.
41. Zalani S., Holley-Guthrie E., Kenney S. Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism. Proc. Natl. Acad. Sci. USA. 93:1996;9194-9199.
42. Zhong W., Wang H., Herndier B., Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc. Natl. Acad. Sci. USA. 93:1996;6641-6646.